Diplomat Pharmacy, Inc. (DPLO) traded within a range of $14.57 to $14.86 after opening the day at $14.86. The company has seen its stock increase in value by 15.95% so far this year. The stock was down close to -1.68% on active volume in last trading session and closed at $14.61 per share. After the recent fall, the stock is currently holding -62.48% below its 52 week high of $38.94 and 19.27% above its 12-month low of $12.25. The shares are up by over 6.41% in the last three months, and the RSI indicator value of 57.2 is neither bullish nor bearish, tempting investors to stay on the sidelines.
Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company’s primary focus is on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. Diplomat Pharmacy, Inc. has 16 pharmacy locations in Arizona, California, Connecticut, Florida, Illinois, Iowa, Maryland, Massachusetts, Michigan, Minnesota, North Carolina, Ohio, and Pennsylvania. The company was founded in 1975 and is headquartered in Flint, Michigan.
Pilgrim’s Pride Corporation (PPC) continued its upward trend with the stock climbing 9.87% or $1.85 to close the day at $20.6 on active trading volume of 2.88M shares, compared to its three month average trading volume of 1.62M. The Greeley Colorado 80634 based company has been outperforming the food – major diversified group over the past 52 weeks, with the stock gaining 2.52%, compared to the industry which has advanced 29.78% over the same period. With RSI of 69.05, the stock should still continue to rise and get closer to its one year target estimate of $22.4, making it a hold for now.
Pilgrim’s Pride Corporation engages in the production, processing, marketing, and distribution of fresh, frozen, and value-added chicken products to retailers, distributors, and foodservice operators in the United States, Mexico, and Puerto Rico. It offers fresh chicken products comprising pre-marinated or non-marinated refrigerated (non-frozen) whole chickens, whole cut-up chickens, and selected chicken parts. The company also provides prepared chicken products, including portion-controlled breast fillets, tenderloins and strips, delicatessen products, salads, formed nuggets and patties, and bone-in chicken parts. The company sells its products to foodservice market, including chain restaurants, food processors, broad-line distributors, and other institutions; and retail market customers comprising grocery store chains, wholesale clubs, and other retail distributors. In addition, it exports chicken products to the Middle East, Asia, the Commonwealth of Independent States, and other countries. Pilgrim’s Pride Corporation was founded in 1946 and is headquartered in Greeley, Colorado. As of December 28, 2014, Pilgrim’s Pride Corporation operates as a subsidiary of JBS USA Holdings, Inc.
AGNC Investment Corp. (AGNC) dropped $-0.06 to close the day at a new closing price of $19.1, a -0.31% decrease in value from its previous closing price that moved the stock 25.4% above its 52 week low of $17.27. A total of 2.87M shares exchanged hands during the day compared with its three month average trading volume of 3.94M. The stock, which fluctuated between $19.08 and $19.23 during the day, currently situated -2.89% below its 52 week high. The stock is up by 2.84% in the past one month and down by -1.19% over the past three months. With a one year target estimate of $19.25 and RSI of 59.36, the stock still has upside potential, making it a hold for now.
AGNC Investment Corp. operates as a real estate investment trust (REIT) in the United States. The company invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by government-sponsored enterprise or by the United States government agency. It funds its investments primarily through short-term borrowings structured as repurchase agreements. The company has elected to be taxed as a REIT under the Internal Revenue Code of 1986 and would not be subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as American Capital Agency Corp. and changed its name to AGNC Investment Corp. in September 2016. AGNC Investment Corp. was founded in 2008 and is based in Bethesda, Maryland.